ConductScience.org, home

Paper20052341

Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea.

Lee DH and 14 others. J Korean Med Sci, 2010. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea. Papers, record 20052341. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20052341

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea.
PubMed
Journal
J Korean Med Sci
PubMed
Year
2010
PubMed
Publication types
Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.18
iCite
Revised in PubMed
2022-03-17
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee DHDae Hyoung
2Chung NGNak Gyun
3Cho BBin
4Kim HKHack Ki
5Kang HJHyoung Jin
6Shin HYHee Young
7Ahn HSHyo Seop
8Yoo KHKeon Hee
9Sung KWKi Woong
10Koo HHHong Hoe
11Kook HHoon
12Hwang TJTai Ju
13Im HJHo Joon
14Seo JJJong Jin
15Park HJHyeon Jin

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
CytarabineMajor topic
IdarubicinMajor topic
Leukemia, Myeloid, AcuteMajor topic
ThioguanineMajor topic
Adolescent
Child
Child, Preschool
Combined Modality Therapy
Cytogenetics
Female
Hematopoietic Stem Cell Transplantation
Humans
Infant
Infant, Newborn
Male
Republic of Korea
Retrospective Studies
Survival Analysis
Young Adult

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1188440Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.Br J Haematol1976https://conductscience.org/library/papers/188440PubMed
21277182Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine.Cancer Res1976https://conductscience.org/library/papers/1277182PubMed
316304571Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials.Leukemia2005https://conductscience.org/library/papers/16304571PubMed
416912228Clinical implications of FLT3 mutations in pediatric AML.Blood2006https://conductscience.org/library/papers/16912228PubMed
58174198
Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia.
Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8174198PubMed
6872077N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent.Cancer Res1977https://conductscience.org/library/papers/872077PubMed
717713551Clinical characteristics and outcomes in patients with t(8;21) acute myeloid leukemia in Japan.Leukemia2008https://conductscience.org/library/papers/17713551PubMed
816304570Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.Leukemia2005https://conductscience.org/library/papers/16304570PubMed
915830007Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era.Leukemia2005https://conductscience.org/library/papers/15830007PubMed
108916313
Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
Semin Hematol1996https://conductscience.org/library/papers/8916313PubMed
1110446497Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.Int J Hematol1999https://conductscience.org/library/papers/10446497PubMed
1217222748The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.Biol Blood Marrow Transplant2007https://conductscience.org/library/papers/17222748PubMed
132253209Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia.Cancer Res1990https://conductscience.org/library/papers/2253209PubMed
1416110030Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.J Clin Oncol2005https://conductscience.org/library/papers/16110030PubMed
156850647Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia.Cancer Res1983https://conductscience.org/library/papers/6850647PubMed
1616304572Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.Leukemia2005https://conductscience.org/library/papers/16304572PubMed
173164731Clinical use of intermediate to high dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in children with acute leukemia.J Clin Pharmacol1988https://conductscience.org/library/papers/3164731PubMed
1812162758Clinical pharmacokinetics of cytarabine formulations.Clin Pharmacokinet2002https://conductscience.org/library/papers/12162758PubMed
1916304569Pediatric acute myeloid leukemia: international progress and future directions.Leukemia2005https://conductscience.org/library/papers/16304569PubMed
203465875
Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length.
J Clin Oncol1986https://conductscience.org/library/papers/3465875PubMed

See all 25 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
29662859Improvement of treatment outcome over 2 decades in children with acute myeloid leukemia.Blood Res2018https://conductscience.org/library/papers/29662859PubMed
23341720Growth after hematopoietic stem cell transplantation in children with acute myeloid leukemia.J Korean Med Sci2013https://conductscience.org/library/papers/23341720PubMed
20508938Double umbilical cord blood transplantation for children and adolescents.Ann Hematol2010https://conductscience.org/library/papers/20508938PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20052341

GET https://conductscience.org/api/papers/v1/20052341/references?page=2